Evidence map›Paper›PMID 35762720›Full record

ArticleProtein science : a publication of the Protein Society2022

Ca

Daisuke Takahashi, Kento Yonezawa, Yuki Okizaki, Jose M M Caaveiro, Tadashi Ueda, Atsushi Shimada, Fumio Sakane, Nobutaka Shimizu

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. CaProtein science : a publication of the Protein Society · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Daisuke TakahashiDepartment of Protein Structure, Function, and Design, Graduate School of Pharmaceutical Science, Kyushu University, Fukuoka, Japan.ORCID 0000-0001-6169-2061
Kento YonezawaPhoton Factory, Institute of Materials Structure Science, High Energy Accelerator Research Organization (KEK), Tsukuba, Japan.
Yuki OkizakiDepartment of Protein Structure, Function, and Design, Graduate School of Pharmaceutical Science, Kyushu University, Fukuoka, Japan.
Jose M M CaaveiroDepartment of Global Healthcare, Graduate School of Pharmaceutical Science, Kyushu University, Fukuoka, Japan.ORCID 0000-0001-5568-2369
Tadashi UedaDepartment of Protein Structure, Function, and Design, Graduate School of Pharmaceutical Science, Kyushu University, Fukuoka, Japan.
Atsushi ShimadaDivision of Structural Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Fumio SakaneDepartment of Chemistry, Graduate School of Science, Chiba University, Chiba, Japan.ORCID 0000-0003-0857-0377
Nobutaka ShimizuPhoton Factory, Institute of Materials Structure Science, High Energy Accelerator Research Organization (KEK), Tsukuba, Japan.
Kyushu University · JPHigh Energy Accelerator Research Organization · JPChiba University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diacylglycerol kinases (DGKs) are multi-domain lipid kinases that modulate the levels of lipid messengers, diacylglycerol, and phosphatidic acid. Recently, increasing attention has been paid to its α isozyme (DGKα) as a potential target for cancer immunotherapy. However, little progress has been made on the structural biology of DGKs, and a detailed understanding of the Ca

Indexed as

Diacylglycerol KinaseDiglyceridesEndopeptidasesScattering, Small AngleX-Ray DiffractionDiacylglycerol KinaseDiglyceridesEndopeptidasescalcium bindingconformational changesDGKαdiacylglycerol kinasesEF-hand domainsmall-angle X-ray scattering

Identifiers

PMID35762720
PMCPMC9202544
OpenAlexW4282961659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.